Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Recent Articles in Archived Articles

Stem Cell Patents Revoked
Apr 3, 2007
Univ. of Wisconsin Can Appeal. More details...
The Day In Review: Roche Picks Up Antibody Firm For $56.5 Million
Apr 2, 2007
CBT 200 Rises 8 Points. More details...
The Week In Review: Barron's Touts Alzheimers Drugs From Wyeth
Apr 2, 2007
CBT 200 Slips 18 Points. More details...
The Day In Review: Novartis Pulls Zelnorm Off The Market
Mar 30, 2007
CBT 200 Climbs 15 Points. More details...
Provegne From Dendreon Recommended By FDA Committee
Mar 30, 2007
Will A Cancer Therapeutic Vaccine Win Final Approval?. More details...
More Articles >>
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital